AKT1 and in situ carcinoma: Irinotecan normaly induces CIS through p21waf1 expression, but Akt inhibition downregulated this pathway, leading instead to the activation of the Noxa pro-apoptotic protein, followed by its binding to Mcl-1 and the consequent induction of apoptosis.